BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Scope & Guideline

Unveiling the complexities of molecular life.

Introduction

Delve into the academic richness of BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0006-291x
PublisherACADEMIC PRESS INC ELSEVIER SCIENCE
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1959 to 2024
AbbreviationBIOCHEM BIOPH RES CO / Biochem. Biophys. Res. Commun.
Frequency52 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address525 B ST, STE 1900, SAN DIEGO, CA 92101-4495

Aims and Scopes

The journal 'Biochemical and Biophysical Research Communications' focuses on the dissemination of significant findings in the fields of biochemistry and biophysics. It serves as a platform for researchers to share their discoveries, particularly those that have implications for human health, disease mechanisms, and therapeutic approaches.
  1. Biochemical Mechanisms and Pathways:
    Research articles that elucidate the biochemical pathways and mechanisms underlying cellular processes, including metabolic pathways, signal transduction, and enzyme activity.
  2. Molecular Biology and Genetics:
    Studies focused on molecular genetics, including gene expression, regulation, and the molecular basis of genetic diseases, utilizing techniques such as CRISPR and RNA interference.
  3. Cellular and Tissue Responses:
    Investigations into how cellular and tissue responses are modulated by various stimuli, including stress, inflammation, and hypoxia, and their implications for disease.
  4. Drug Discovery and Therapeutics:
    Research that explores pharmacological interventions, drug mechanisms, and the development of new therapeutic agents for diseases, particularly cancer and metabolic disorders.
  5. Structural Biology and Biophysics:
    Studies utilizing advanced imaging and structural analysis techniques to understand the molecular architecture and dynamics of biological macromolecules.
  6. Microbiology and Immunology:
    Research focusing on the interactions between host and pathogens, including the immune response to infections and the role of microbiota in health and disease.
  7. Bioinformatics and Computational Biology:
    Utilization of computational methods to analyze biological data, including gene expression profiles, protein interactions, and metabolic pathways.
The journal is evolving with the scientific landscape, with several emerging themes gaining traction in recent publications. These themes reflect current trends in biochemistry and biophysics research, highlighting innovative approaches and interdisciplinary studies.
  1. Ferroptosis and Cell Death Mechanisms:
    An increasing number of studies are focusing on ferroptosis as a regulated form of cell death, particularly in cancer research, highlighting its implications in therapeutic resistance.
  2. Microbiome and Metabolomics:
    Research exploring the role of the microbiome in health and disease is gaining prominence, particularly in relation to metabolic disorders and immune responses.
  3. CRISPR and Genome Editing Technologies:
    The application of CRISPR and other genome editing technologies is trending, with numerous papers discussing their potential for therapeutic interventions and functional genomics.
  4. Nanotechnology in Drug Delivery:
    Emerging studies are focusing on the use of nanotechnology for targeted drug delivery systems, enhancing the efficacy and specificity of treatments for various diseases.
  5. Bioinformatics and Systems Biology:
    The integration of bioinformatics approaches to analyze complex biological data is increasingly popular, particularly in understanding disease mechanisms and personalizing medicine.
  6. Vascular Biology and Regenerative Medicine:
    Research in vascular biology, particularly in relation to regenerative medicine and tissue engineering, is trending, focusing on novel therapeutic strategies for vascular diseases.
  7. Immunotherapy and Cancer Treatment:
    The exploration of novel immunotherapeutic strategies, including the use of immune checkpoint inhibitors and CAR-T cell therapies, is a rapidly growing area of research.

Declining or Waning

While certain areas within the journal's scope continue to thrive, others are witnessing a decline in publication frequency or research interest. The following themes are becoming less prominent.
  1. Traditional Pharmacology:
    Research focusing solely on traditional pharmacological approaches without integration of modern techniques such as molecular biology or genetic engineering is declining.
  2. Basic Biochemical Assays:
    Studies that rely on basic biochemical assays without novel insights or applications are becoming less frequent as the field advances towards more complex and integrated approaches.
  3. Single-Cell Studies without Context:
    Publications that focus on single-cell studies but lack contextual understanding of tissue microenvironments or systemic interactions are seeing reduced interest.
  4. In vitro Models with Limited Relevance:
    Research utilizing in vitro models that do not adequately mimic in vivo conditions are less favored as the demand for more relevant models increases.

Similar Journals

Frontiers in Molecular Biosciences

Fostering Collaboration in Cutting-Edge Molecular Research
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Molecular Biosciences is an esteemed open-access journal published by FRONTIERS MEDIA SA, based in Switzerland. Since its inception in 2014, the journal has made significant strides in the fields of biochemistry, genetics, and molecular biology, cementing its reputation with a solid position in the Q1 quartile for both Biochemistry and Genetics and Molecular Biology (miscellaneous) categories as of 2023. With a remarkable Scopus rank of #14/103 in the combined categories, it offers an essential platform for the dissemination of high-quality research that shapes the understanding of molecular processes and their implications in health and disease. The journal’s commitment to open access facilitates the broadest possible reach for groundbreaking discoveries, serving as a vital resource for researchers, professionals, and students alike. Located at AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, this journal continues to foster innovative discussions and advancements in molecular biosciences, paving the way for new insights and collaborations in the scientific community.

MOLECULAR AND CELLULAR BIOLOGY

Driving Innovation in Molecular and Cellular Science
Publisher: TAYLOR & FRANCIS INCISSN: 0270-7306Frequency: 24 issues/year

MOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.

Doklady Biochemistry and Biophysics

Advancing the Frontiers of Biochemical and Biophysical Research
Publisher: MAIK NAUKA/INTERPERIODICA/SPRINGERISSN: 1607-6729Frequency: 6 issues/year

Doklady Biochemistry and Biophysics is a vital resource for the advancement of knowledge in the fields of biochemistry and biophysics, published by MAIK NAUKA/INTERPERIODICA/SPRINGER. Featuring an ISSN of 1607-6729 and an E-ISSN of 1608-3091, this journal plays a critical role in disseminating research findings and fostering scholarly discourse. Despite its recent ranking in the Q4 quartile for biochemistry and biophysics in 2023, it serves as an essential platform for researchers exploring these intertwined disciplines. The journal’s scope encompasses a wide variety of topics, enhancing the understanding of biochemical processes and physical principles in biological systems. With converged years of publication from 2001 to 2024, it stands as a continual source of knowledge for its readers, who include researchers, professionals, and students alike. While the journal currently does not offer open access options, its contributions remain significant within the scholarly community, illustrated by its competitive Scopus rankings across related fields.

FEBS LETTERS

Fostering Knowledge Exchange in Life Sciences
Publisher: WILEYISSN: 0014-5793Frequency: 24 issues/year

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Fostering Innovation in Molecular Analysis
Publisher: TAYLOR & FRANCIS LTDISSN: 1040-9238Frequency: 6 issues/year

Welcome to Critical Reviews in Biochemistry and Molecular Biology, a premier academic journal published by Taylor & Francis Ltd, dedicated to advancing the fields of biochemistry and molecular biology. With an impressive impact factor and a Q1 ranking in both Biochemistry and Molecular Biology for 2023, this journal serves as a vital resource for researchers, professionals, and students eager to engage with cutting-edge reviews and analyses that synthesize the latest developments in these dynamic areas of study. Since its inception in 1972, the journal has maintained a commitment to high-quality scholarship, providing a platform for critical discussions that accelerate the discovery and understanding of biochemical processes and molecular interactions. Although not open access, its robust editorial peer-review process ensures that published articles meet the highest standards of scientific rigor, making it a trusted source for the scientific community. As we continue to converge toward 2024, we invite you to explore the extensive array of topics and findings that have shaped contemporary biochemistry and molecular biology.

MOLECULES AND CELLS

Driving Progress in Cellular and Molecular Medicine
Publisher: KOREAN SOC MOLECULAR & CELLULAR BIOLOGYISSN: 1016-8478Frequency: 12 issues/year

MOLECULES AND CELLS is a distinguished peer-reviewed journal published by the Korean Society for Molecular and Cellular Biology, dedicated to advancing the fields of Cell Biology, Molecular Biology, and Medicine. With a solid citation record and a robust reputation in its respective categories, the journal has achieved a ranking of Q2 in Cell Biology and Q1 in Miscellaneous Medicine as of 2023, demonstrating its impact and relevance to ongoing research in these vital disciplines. Although currently not open access, MOLECULES AND CELLS strives to provide a platform for innovative studies from diverse areas within molecular and cellular research, fostering collaboration among scientists worldwide. Established in 1996 and continuing to publish leading-edge research until 2024, this journal is essential for researchers, professionals, and students seeking to engage with the latest developments and insights in the life sciences.

IUBMB LIFE

Catalyzing Breakthroughs in Biochemical Knowledge
Publisher: WILEYISSN: 1521-6543Frequency: 12 issues/year

IUBMB LIFE is a prestigious, peer-reviewed journal published by WILEY, dedicated to advancing the fields of biochemistry, molecular biology, and cell biology. With an impressive impact factor and consistently ranked in the Q1 and Q2 categories across multiple relevant disciplines—including Biochemistry, Genetics, and Clinical Biochemistry—this journal has established itself as a leading platform for disseminating innovative research and critical reviews that propel scientific discovery. The journal spans a converged publication period from 1999 to 2024, providing comprehensive insights into the dynamic landscape of biochemical research. Researchers, professionals, and students alike are invited to explore its Open Access options, ensuring that groundbreaking studies are accessible to a global audience. As it continues to shape the future of life sciences, IUBMB LIFE remains a vital resource for those seeking to enrich their understanding and contribute to these rapidly evolving fields.

TRENDS IN BIOCHEMICAL SCIENCES

Unveiling the Latest Trends in Biochemistry
Publisher: CELL PRESSISSN: 0968-0004Frequency: 12 issues/year

TRENDS IN BIOCHEMICAL SCIENCES is a premier academic journal published by CELL PRESS, focusing on the latest advancements and insights in the dynamic fields of biochemistry and molecular biology. With an ISSN of 0968-0004 and an E-ISSN of 1362-4326, this journal has established itself as a leading source of high-impact research, boasting an impressive Q1 category ranking in both Biochemistry and Molecular Biology as of 2023. The journal's Scopus Ranks further highlight its significance, placing it in the top 3% and 4% of its respective fields, emphasizing its role as a vital platform for disseminating innovative research. Published since 1976 and continuing through 2024, TRENDS IN BIOCHEMICAL SCIENCES provides a comprehensive overview of the latest trends, methods, and applications, helping researchers, professionals, and students stay at the forefront of their disciplines. Although it offers traditional access options, the journal's rich content and authoritative analysis make it a must-read for those pursuing cutting-edge biochemical research.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Transforming Knowledge into Innovation in Life Sciences.
Publisher: SCIENCE PRESSISSN: 1672-9145Frequency: 12 issues/year

ACTA BIOCHIMICA ET BIOPHYSICA SINICA, an esteemed journal published by SCIENCE PRESS, is a leading platform in the fields of biochemistry, biophysics, and molecular biology. Based in the United Kingdom, this journal has consistently ranked in the Q2 category for Biochemistry, Biophysics, and Medicine (miscellaneous) in 2023, showcasing its commitment to high-quality research and innovation in life sciences. With a convergence period extending from 1996 to 2024, it features critical insights into biochemical and biophysical processes that underlie biological phenomena. Researchers and professionals seeking to stay at the forefront of discoveries will find its articles to be both informative and transformative. Although not an open-access journal, ACTA BIOCHIMICA ET BIOPHYSICA SINICA aims to advance knowledge and foster collaboration among scientists worldwide, emphasizing its role in the dynamic landscape of biomedical research.

CELLULAR SIGNALLING

Elevating Insights into Cellular Communication
Publisher: ELSEVIER SCIENCE INCISSN: 0898-6568Frequency: 12 issues/year

CELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.